Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA

December 2015

Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA. It won't just be for COPD anymore.

But don't expect to use it first-line for asthma.

Adding Spiriva to a medium-dose inhaled steroid may improve lung function similar to adding a long-acting beta-agonist (salmeterol, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Help Patients Give Metformin a Fair Chance
Geriatrics Think of Beers Criteria as a "Warning Light" Rather Than a "Stop Sign"
Opioids Help Patients Buy-In to Tapering Off Opioids
Anticoagulants Consider Praxbind to Reverse Pradaxa In Patients with Life-Threatening Bleeding
Endocarditis Help Your Endocarditis Patients Complete Appropriate IV Antibiotics at Home
Alcohol Educate Patients at Discharge About Alcohol Interactions
Supplements Caution Patients About Supplements That Can Land Them In The Emergency Dept.
Aspirin Think of Durlaza as an Expensive Way to Get Low-Dose Aspirin
Fractures Avoid Canagliflozin (Invokana) in Patients at Risk of Fractures
Asthma Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA
Respiratory & Allergy Consider Adrenaclick or Its Generic Epinephrine Auto-Injector Instead of EpiPen